However, the exploration of this study regarding the p53 signaling pathway is insufficiently robust, lacking strong evidence like western blotting and immunofluorescence to demonstrate the activation of the p53 signal in breast cancer cells. This evidence concerns the gene TP53 and breast carcinoma.